Physical activity and autoimmune diseases: Get moving and manage the disease

Autoimmunity Reviews

Volumn 17, Issue 1, 2018, Pages 53-72

  Sharif, Kassem ^a,b,c   Watad, Abdulla ^a,b,c   Bragazzi, Nicola Luigi ^d   Lichtbroun, Micheal ^b,c   Amital, Howard ^a,b,c   Shoenfeld, Yehuda ^b,c  

^a Department of Medicine ‘B’ ^*  (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Autoimmune diseases; Barriers; Exercise; Immune system; Physical activity

Indexed keywords

CYTOKINE; HORMONE; LIPID;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; BONE DENSITY; CACHEXIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; CYTOKINE RELEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FATIGUE; FIBROMYALGIA; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATORY BOWEL DISEASE; INNATE IMMUNITY; INSULIN DEPENDENT DIABETES MELLITUS; JOINT MOBILITY; KINESIOTHERAPY; MOOD; MULTIPLE SCLEROSIS; NONHUMAN; PHYSICAL ACTIVITY; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; EXERCISE; IMMUNOLOGY; PHYSIOLOGY; PSYCHOLOGY; QUALITY OF LIFE; RISK FACTOR;

AUTOIMMUNE DISEASES; EXERCISE; HUMANS; QUALITY OF LIFE; RISK FACTORS;

EID: 85033576957     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.11.010     Document Type: Review

References (278)

1. Caspersen, C.J., Powell, K.E., Christenson, G.M., Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research. Public Health Rep 100:2 (1985), 126–131.
2. Ding, D., Lawson, K.D., Kolbe-Alexander, T.L., Finkelstein, E.A., Katzmarzyk PT, van Mechelen W, et al. The economic burden of physical inactivity: a global analysis of major non-communicable diseases. Lancet. 388:10051 (2016), 1311–1324.
3. Laaksonen, D.E., Lakka, H.M., Salonen, J.T., Niskanen, L.K., Rauramaa, R., Lakka, T.A., Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome. Diabetes Care 25:9 (2002), 1612–1618.
4. Smith, D.A., Germolec, D.R., Introduction to immunology and autoimmunity. Environ Health Perspect 107:Suppl. 5 (1999), 661–665.
5. Gravina, G., Wasen, C., Garcia-Bonete, M.J., Turkkila, M., Erlandsson, M.C., Toyra Silfversward, S., et al. Survivin in autoimmune diseases. Autoimmun Rev 16:8 (2017), 845–855.
6. Lorenz, H.M., Herrmann, M., Kalden, J.R., The pathogenesis of autoimmune diseases. Scand J Clin Lab Investig Suppl 235 (2001), 16–26.
7. Sharif, K., Watad, A., Bragazzi, N.L., Adawi, M., Amital, H., Shoenfeld, Y., Coffee and autoimmunity: more than a mere hot beverage!. Autoimmun Rev 16:7 (2017), 712–721.
8. Coronel-Restrepo, N., Posso-Osorio, I., Naranjo-Escobar, J., Tobon, G.J., Autoimmune diseases and their relation with immunological, neurological and endocrinological axes. Autoimmun Rev 16:7 (2017), 684–692.
9. Watad, A., Azrielant, S., Bragazzi, N.L., Sharif, K., David, P., Katz, I., et al. Seasonality and autoimmune diseases: the contribution of the four seasons to the mosaic of autoimmunity. J Autoimmun 82 (2017), 13–30.
10. Rosman, Z., Shoenfeld, Y., Zandman-Goddard, G., Biologic therapy for autoimmune diseases: an update. BMC Med, 11, 2013, 88.
11. Chandrashekara, S., The treatment strategies of autoimmune disease may need a different approach from conventional protocol: a review. Indian J Pharm 44:6 (2012), 665–671.
12. Rosato, E., Pisarri, S., Salsano, F., Current strategies for the treatment of autoimmune diseases. J Biol Regul Homeost Agents 24:3 (2010), 251–259.
13. McCarthy, D., Dale, M., The leucocytosis of exercise. Sports Med 6:6 (1988), 333–363.
14. Navalta, J., Sedlock, D., Park, K.-S., Effect of exercise intensity on exercise-induced lymphocyte apoptosis. Int J Sports Med 28:06 (2007), 539–542.
15. Morel, P.A., Oriss, T.B., Crossregulation between Th1 and Th2 cells. Crit Rev Immunol 18:4 (1998), 275–303.
16. Steensberg, A., Toft, A.D., Bruunsgaard, H., Sandmand, M., Halkjaer-Kristensen, J., Pedersen, B.K., Strenuous exercise decreases the percentage of type 1 T cells in the circulation. J Appl Physiol (1985) 91:4 (2001), 1708–1712.
17. Elenkov, I.J., Chrousos, G.P., Stress hormones, Th1/Th2 patterns, pro/anti-inflammatory cytokines and susceptibility to disease. Trends Endocrinol Metab 10:9 (1999), 359–368.
18. Pedersen, B.K., Hoffman-Goetz, L., Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev, 80(3), 2000, 1055.
19. Kakanis, M.W., Peake, J., Brenu, E.W., Simmonds, M., Gray, B., Marshall-Gradisnik, S.M., T helper cell cytokine profiles after endurance exercise. J Interferon Cytokine Res 34:9 (2014), 699–706.
20. Xiang, L., Rehm, K.E., Marshall, G.D. Jr., Effects of strenuous exercise on Th1/Th2 gene expression from human peripheral blood mononuclear cells of marathon participants. Mol Immunol 60:2 (2014), 129–134.
21. Sharpe, A.H., Freeman, G.J., The B7-CD28 superfamily. Nat Rev Immunol 2:2 (2002), 116–126.
22. Crane, I.J., Forrester, J.V., Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol 25:2 (2005), 75–102.
23. Rudensky, A.Y., Regulatory T cells and Foxp3. Immunol Rev 241:1 (2011), 260–268.
24. Schwindt, C.D., Zaldivar, F., Wilson, L., Leu, S.Y., Wang-Rodriguez, J., Mills, P.J., et al. Do circulating leucocytes and lymphocyte subtypes increase in response to brief exercise in children with and without asthma?. Br. J. Sports Med. 41:1 (2007), 34–40.
25. Wilson, L.D., Zaldivar, F.P., Schwindt, C.D., Wang-Rodriguez, J., Cooper, D.M., Circulating T-regulatory cells, exercise and the elite adolescent swimmer. Pediatr Exerc Sci 21:3 (2009), 305–317.
26. Weinhold, M., Shimabukuro-Vornhagen, A., Franke, A., Theurich, S., Wahl, P., Hallek, M., et al. Physical exercise modulates the homeostasis of human regulatory T cells. J Allergy Clin Immunol 137:5 (2016), 1607–1610.e8.
27. Nielsen, H., Pedersen, B., Lymphocyte proliferation in response to exercise. Eur J Appl Physiol Occup Physiol 75:5 (1997), 375–379.
28. Tomasi, T.B., Trudeau, F.B., Czerwinski, D., Erredge, S., Immune parameters in athletes before and after strenuous exercise. J Clin Immunol 2:3 (1982), 173–178.
29. Tharp, G.D., Barnes, M.W., Reduction of saliva immunoglobulin levels by swim training. Eur J Appl Physiol Occup Physiol 60:1 (1990), 61–64.
30. Tvede, N., Heilmann, C., Halkjaer-Kristensen, J., Pedersen, B., Mechanisms of B-lymphocyte suppression induced by acute physical exercise. J Clin Lab Immunol 30:4 (1989), 169–173.
31. Cooper, M.A., Fehniger, T.A., Caligiuri, M.A., The biology of human natural killer-cell subsets. Trends Immunol 22:11 (2001), 633–640.
32. Pedersen, B.K., Ullum, H., NK cell response to physical activity: possible mechanisms of action. Med Sci Sports Exerc 26:2 (1994), 140–146.
33. Timmons, B.W., Cieslak, T., Human natural killer cell subsets and acute exercise: a brief review. Exerc Immunol Rev 14 (2008), 8–23.
34. Suzui, M., Kawai, T., Kimura, H., Takeda, K., Yagita, H., Okumura, K., et al. Natural killer cell lytic activity and CD56(dim) and CD56(bright) cell distributions during and after intensive training. J Appl Physiol (1985) 96:6 (2004), 2167–2173.
35. Summers, C., Rankin, S.M., Condliffe, A.M., Singh, N., Peters, A.M., Chilvers, E.R., Neutrophil kinetics in health and disease. Trends Immunol 31:8 (2010), 318–324.
36. Pyne, D.B., Regulation of neutrophil function during exercise. Sports Med 17:4 (1994), 245–258.
37. Wolach, B., Falk, B., Gavrieli, R., Kodesh, E., Eliakim, A., Neutrophil function response to aerobic and anaerobic exercise in female judoka and untrained subjects. Br J Sports Med 34:1 (2000), 23–28.
38. Ortega, E., Collazos, M.E., Maynar, M., Barriga, C., De la Fuente, M., Stimulation of the phagocytic function of neutrophils in sedentary men after acute moderate exercise. Eur J Appl Physiol Occup Physiol 66:1 (1993), 60–64.
39. Smith, J., McKenzie, S., Telford, R., Weidemann, M., Why does moderate exercise enhance, but intense training depress, immunity. Behavior and immunity, 1992, 155–168.
40. Fujiwara, N., Kobayashi, K., Macrophages in inflammation. Curr Drug Targets Inflamm Allergy 4:3 (2005), 281–286.
41. Gleeson, M., McFarlin, B., Flynn, M., Exercise and toll-like receptors. Exerc Immunol Rev 12:1 (2006), 34–53.
42. Kizaki, T., Takemasa, T., Sakurai, T., Izawa, T., Hanawa, T., Kamiya, S., et al. Adaptation of macrophages to exercise training improves innate immunity. Biochem Biophys Res Commun 372:1 (2008), 152–156.
43. Northoff, H., Berg, A., Immunologic mediators as parameters of the reaction to strenuous exercise. Int J Sports Med 12:Suppl. 1 (1991), S9–15.
44. Sprenger, H., Jacobs, C., Nain, M., Gressner, A.M., Prinz, H., Wesemann, W., et al. Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol 63:2 (1992), 188–195.
45. Bruunsgaard, H., Galbo, H., Halkjaer-Kristensen, J., Johansen, T.L., MacLean, D.A., Pedersen, B.K., Exercise-induced increase in serum interleukin-6 in humans is related to muscle damage. J Physiol 499:Pt 3 (1997), 833–841.
46. Muñoz-Cánoves, P., Scheele, C., Pedersen, B.K., Serrano, A.L., Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword?. FEBS J 280:17 (2013), 4131–4148.
47. Nieman, D.C., Nehlsen-Cannarella, S.L., Fagoaga, O.R., Henson, D.A., Utter, A., Davis, J.M., et al. Influence of mode and carbohydrate on the cytokine response to heavy exertion. Med Sci Sports Exerc 30:5 (1998), 671–678.
48. Steensberg, A., Fischer, C.P., Keller, C., Moller, K., Pedersen, B.K., IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. Am J Physiol Endocrinol Metab 285:2 (2003), E433–E437.
49. de Vries, J.E., Immunosuppressive and anti-inflammatory properties of interleukin 10. Ann Med 27:5 (1995), 537–541.
50. Kjaer, M., Dela, F., Endocrine responses to exercise. Exercise and immune function, 13, 1996, 231–256.
51. Madden, K.S., Felten, D.L., Experimental basis for neural-immune interactions. Physiol Rev 75:1 (1995), 77–107.
52. Carlson, S.L., Brooks, W.H., Roszman, T.L., Neurotransmitter-lymphocyte interactions: dual receptor modulation of lymphocyte proliferation and cAMP production. J Neuroimmunol 24:1 (1989), 155–162.
53. Wehbi, V.L., Taskén, K., Molecular mechanisms for cAMP-mediated immunoregulation in T cells – role of anchored protein kinase a signaling units. Front Immunol, 7, 2016.
54. Hill, E.E., Zack, E., Battaglini, C., Viru, M., Viru, A., Hackney, A.C., Exercise and circulating cortisol levels: the intensity threshold effect. J Endocrinol Investig 31:7 (2008), 587–591.
55. Rabin, B., Moyna, M., Kusnecov, A., Zhou, D., Shurin, M., Neuroendocrine effects of immunity. Exercise and immune function, 1996, 21–38.
56. Maisel, A.S., Harris, T., Rearden, C.A., Michel, M.C., Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. Circulation 82:6 (1990), 2003–2010.
57. Van Den Bergh, P., Rozing, J., Nagelkerken, L., Identification of two moieties of beta-endorphin with opposing effects on rat T-cell proliferation. Immunology, 79(1), 1993, 18.
58. Morgan, E.L., McClurg, M.R., Janda, J.A., Suppression of human B lymphocyte activation by ß-endorphin. J Neuroimmunol 28:3 (1990), 209–217.
59. Mathews, P.M., Froelich, C., Sibbitt, W., Bankhurst, A., Enhancement of natural cytotoxicity by beta-endorphin. J Immunol 130:4 (1983), 1658–1662.
60. Araneo, B.A., Dowell, T., Diegel, M., Daynes, R.A., Dihydrotestosterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma-interferon, but not IL-2 by activated murine T cells. Blood 78:3 (1991), 688–699.
61. Kanda, N., Tsuchida, T., Tamaki, K., Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 106:2 (1996), 410–415.
62. McInnes, I.B., Schett, G., The pathogenesis of rheumatoid arthritis. N Engl J Med 365:23 (2011), 2205–2219.
63. Schneider, M., Krüger, K., Rheumatoid arthritis—early diagnosis and disease management. Dtsch Arztebl Int 110:27–28 (2013), 477–484.
64. Sandigursky, S., Silverman, G.J., Mor, A., Targeting the programmed cell death-1 pathway in rheumatoid arthritis. Autoimmun Rev 16:8 (2017), 767–773.
65. Drossaers-Bakker, K.W., Zwinderman, A.H., Vliet Vlieland, T.P., Van Zeben, D., Vos, K., Breedveld, F.C., et al. Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 47:4 (2002), 383–390.
66. Leblond, A., Allanore, Y., Avouac, J., Targeting synovial neoangiogenesis in rheumatoid arthritis. Autoimmun Rev 16:6 (2017), 594–601.
67. Keefe, F.J., Somers, T.J., Martire, L.M., Psychological interventions and lifestyle modifications for arthritis pain management. Rheum Dis Clin N Am 34:2 (2008), 351–368.
68. Pinto, A.J., Roschel, H., de Sa Pinto, A.L., Lima, F.R., Pereira, R.M.R., Silva, C.A., et al. Physical inactivity and sedentary behavior: overlooked risk factors in autoimmune rheumatic diseases?. Autoimmun Rev 16:7 (2017), 667–674.
69. Di Giuseppe, D., Bottai, M., Askling, J., Wolk, A., Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study. Arthritis Res Ther, 17(1), 2015.
70. Repping-Wuts, H., Uitterhoeve, R., van Riel, P., van Achterberg, T., Fatigue as experienced by patients with rheumatoid arthritis (RA): a qualitative study. Int J Nurs Stud 45:7 (2008), 995–1002.
71. Gettings, L., Psychological well-being in rheumatoid arthritis: a review of the literature. Musculoskeletal Care 8:2 (2010), 99–106.
72. Douglas, K.M., Pace, A.V., Treharne, G.J., Saratzis, A., Nightingale, P., Erb, N., et al. Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome. Ann Rheum Dis 65:3 (2006), 348–353.
73. Tierney, M., Fraser, A., Kennedy, N., Physical activity in rheumatoid arthritis: a systematic review. J Phys Act Health 9:7 (2012), 1036–1048.
74. Sokka, T., Hakkinen, A., Kautiainen, H., Maillefert, J.F., Toloza, S., Mork Hansen, T., et al. Physical inactivity in patients with rheumatoid arthritis: data from twenty-one countries in a cross-sectional, international study. Arthritis Rheum 59:1 (2008), 42–50.
75. Veldhuijzen van Zanten, J., Rouse, P.C., Hale, E.D., Ntoumanis, N., Metsios, G.S., Duda, J.L., et al. Perceived barriers, facilitators and benefits for regular physical activity and exercise in patients with rheumatoid arthritis: a review of the literature. Sports Med 45:10 (2015), 1401–1412.
76. Sandberg, M.E., Wedren, S., Klareskog, L., Lundberg, I.E., Opava, C.H., Alfredsson, L., et al. Patients with regular physical activity before onset of rheumatoid arthritis present with milder disease. Ann Rheum Dis 73:8 (2014), 1541–1544.
77. Crowson, C.S., Liao, K.P., Davis, J.M., Solomon, D.H., Matteson, E.L., Knutson, K.L., et al. Rheumatoid arthritis and cardiovascular disease. Am Heart J 166:4 (2013), 622–628.e1.
78. Dhawan, S.S., Quyyumi, A.A., Rheumatoid arthritis and cardiovascular disease. Curr Atheroscler Rep 10:2 (2008), 128–133.
79. Prati, C., Demougeot, C., Guillot, X., Godfrin-Valnet, M., Wendling, D., Endothelial dysfunction in joint disease. Joint Bone Spine 81:5 (2014), 386–391.
80. Metsios, G.S., Stavropoulos-Kalinoglou, A., Panoulas, V.F., Wilson, M., Nevill, A.M., Koutedakis, Y., et al. Association of physical inactivity with increased cardiovascular risk in patients with rheumatoid arthritis. Eur J Cardiovasc Prev Rehabil 16:2 (2009), 188–194.
81. Metsios, G.S., Stavropoulos-Kalinoglou, A., Veldhuijzen van Zanten, J.J., Nightingale, P., Sandoo, A., Dimitroulas, T., et al. Individualised exercise improves endothelial function in patients with rheumatoid arthritis. Ann Rheum Dis 73:4 (2013), 748–751.
82. Metsios, G.S., Stavropoulos-Kalinoglou, A., Sandoo, A., van Zanten, J.J., Toms, T.E., John, H., et al. Vascular function and inflammation in rheumatoid arthritis: the role of physical activity. Open Cardiovasc Med J 4 (2010), 89–96.
83. DeSouza, C.A., Shapiro, L.F., Clevenger, C.M., Dinenno, F.A., Monahan, K.D., Tanaka, H., et al. Regular aerobic exercise prevents and restores age-related declines in endothelium-dependent vasodilation in healthy men. Circulation 102:12 (2000), 1351–1357.
84. Frangos, J.A., Eskin, S.G., McIntire, L.V., Ives, C.L., Flow effects on prostacyclin production by cultured human endothelial cells. Science 227:4693 (1985), 1477–1479.
85. Tuttle, J.L., Nachreiner, R.D., Bhuller, A.S., Condict, K.W., Connors, B.A., Herring, B.P., et al. Shear level influences resistance artery remodeling: wall dimensions, cell density, and eNOS expression. Am J Physiol Heart Circ Physiol 281:3 (2001), H1380–9.
86. McLaughlin, T., Abbasi, F., Lamendola, C., Liang, L., Reaven, G., Schaaf, P., et al. Differentiation between obesity and insulin resistance in the association with C-reactive protein. Circulation 106:23 (2002), 2908–2912.
87. Lemmey, A.B., Marcora, S.M., Chester, K., Wilson, S., Casanova, F., Maddison, P.J., Effects of high-intensity resistance training in patients with rheumatoid arthritis: a randomized controlled trial. Arthritis Rheum 61:12 (2009), 1726–1734.
88. Roubenoff, R., Roubenoff, R.A., Ward, L.M., Holland, S.M., Hellmann, D.B., Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol 19:10 (1992), 1505–1510.
89. Roubenoff, R., Roubenoff, R.A., Cannon, J.G., Kehayias, J.J., Zhuang, H., Dawson-Hughes, B., et al. Rheumatoid cachexia: cytokine-driven hypermetabolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 93:6 (1994), 2379–2386.
90. Gibson, J.N., Poyser, N.L., Morrison, W.L., Scrimgeour, C.M., Rennie, M.J., Muscle protein synthesis in patients with rheumatoid arthritis: effect of chronic corticosteroid therapy on prostaglandin F2 alpha availability. Eur J Clin Investig 21:4 (1991), 406–412.
91. Adams, G.R., Invited review: autocrine/paracrine IGF-I and skeletal muscle adaptation. J Appl Physiol (1985) 93:3 (2002), 1159–1167.
92. Marcora, S.M., Lemmey, A.B., Maddison, P.J., Can progressive resistance training reverse cachexia in patients with rheumatoid arthritis? Results of a pilot study. J Rheumatol 32:6 (2005), 1031–1039.
93. Hakkinen, A., Pakarinen, A., Hannonen, P., Kautiainen, H., Nyman, K., Kraemer, W.J., et al. Effects of prolonged combined strength and endurance training on physical fitness, body composition and serum hormones in women with rheumatoid arthritis and in healthy controls. Clin Exp Rheumatol 23:4 (2005), 505–512.
94. Franck, H., Gottwalt, J., Peripheral bone density in patients with rheumatoid arthritis. Clin Rheumatol 28:10 (2009), 1141–1145.
95. Hakkinen, A., Sokka, T., Kotaniemi, A., Kautiainen, H., Jappinen, I., Laitinen, L., et al. Dynamic strength training in patients with early rheumatoid arthritis increases muscle strength but not bone mineral density. J Rheumatol 26:6 (1999), 1257–1263.
96. Häkkinen, A., Sokka, T., Kotaniemi, A., Hannonen, P., A randomized two-year study of the effects of dynamic strength training on muscle strength, disease activity, functional capacity, and bone mineral density in early rheumatoid arthritis. Arthritis Rheum 44:3 (2001), 515–522.
97. de Jong, Z., Munneke, M., Zwinderman, A.H., Kroon, H.M., Ronday, K.H., Lems, W.F., et al. Long term high intensity exercise and damage of small joints in rheumatoid arthritis. Ann Rheum Dis 63:11 (2004), 1399–1405.
98. de Jong, Z., Munneke, M., Zwinderman, A.H., Kroon, H.M., Jansen, A., Ronday, K.H., et al. Is a long-term high-intensity exercise program effective and safe in patients with rheumatoid arthritis? Results of a randomized controlled trial. Arthritis Rheum 48:9 (2003), 2415–2424.
99. Metsios, G.S., Stavropoulos-Kalinoglou, A., Veldhuijzen van Zanten, J.J., Treharne, G.J., Panoulas, V.F., Douglas, K.M., et al. Rheumatoid arthritis, cardiovascular disease and physical exercise: a systematic review. Rheumatology (Oxford) 47:3 (2008), 239–248.
100. van den Ende, C.H.M., Breedveld, F.C., le Cessie, S., Dijkmans, B.A.C., de Mug, A.W., Hazes, J.M.W., Effect of intensive exercise on patients with active rheumatoid arthritis: a randomised clinical trial. Ann Rheum Dis 59:8 (2000), 615–621.
101. van Hoogmoed, D., Fransen, J., Bleijenberg, G., van Riel, P., Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology (Oxford) 49:7 (2010), 1294–1302.
102. Neuberger, G.B., Press, A.N., Lindsley, H.B., Hinton, R., Cagle, P.E., Carlson, K., et al. Effects of exercise on fatigue, aerobic fitness, and disease activity measures in persons with rheumatoid arthritis. Res Nurs Health 20:3 (1997), 195–204.
103. Neill, J., Belan, I., Ried, K., Effectiveness of non-pharmacological interventions for fatigue in adults with multiple sclerosis, rheumatoid arthritis, or systemic lupus erythematosus: a systematic review. J Adv Nurs 56:6 (2006), 617–635.
104. Rall, L.C., Meydani, S.N., Kehayias, J.J., Dawson-Hughes, B., Roubenoff, R., The effect of progressive resistance training in rheumatoid arthritis. Increased strength without changes in energy balance or body composition. Arthritis Rheum 39:3 (1996), 415–426.
105. Løppenthin, K., Esbensen, B.A., Østergaard, M., Jennum, P., Tolver, A., Aadahl, M., et al. Physical activity and the association with fatigue and sleep in Danish patients with rheumatoid arthritis. Rheumatol Int 35:10 (2015), 1655–1664.
106. Goldenberg, M.M., Multiple sclerosis review. Pharm Ther 37:3 (2012), 175–184.
107. Calabresi, P.A., Diagnosis and management of multiple sclerosis. Am Fam Physician 70:10 (2004), 1935–1944.
108. Casserly, C.S., Nantes, J.C., Whittaker Hawkins, R.F., Vallieres, L., Neutrophil perversion in demyelinating autoimmune diseases: mechanisms to medicine. Autoimmun Rev 16:3 (2017), 294–307.
109. Coyle, P.K., Symptom management and lifestyle modifications in multiple sclerosis. Continuum (Minneap Minn) 22:3 (2016), 815–836.
110. Dorans, K.S., Massa, J., Chitnis, T., Ascherio, A., Munger, K.L., Physical activity and the incidence of multiple sclerosis. Neurology 87:17 (2016), 1770–1776.
111. White, L.J., Castellano, V., Exercise and brain health—implications for multiple sclerosis: part 1—neuronal growth factors. Sports Med 38:2 (2008), 91–100.
112. Warren, S.A., Warren, K.G., Greenhill, S., Paterson, M., How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Assoc J 126:4 (1982), 377–382 [85].
113. Ghadirian, P., Dadgostar, B., Azani, R., Maisonneuve, P., A case-control study of the association between socio-demographic, lifestyle and medical history factors and multiple sclerosis. Can J Public Health 92:4 (2001), 281–285.
114. Motl, R.W., McAuley, E., Snook, E.M., Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 11:4 (2005), 459–463.
115. Kister, I., Chamot, E., Salter, A.R., Cutter, G.R., Bacon, T.E., Herbert, J., Disability in multiple sclerosis: a reference for patients and clinicians. Neurology 80:11 (2013), 1018–1024.
116. Vanner, E.A., Block, P., Christodoulou, C.C., Horowitz, B.P., Krupp, L.B., Pilot study exploring quality of life and barriers to leisure-time physical activity in persons with moderate to severe multiple sclerosis. Disabil Health J 1:1 (2008), 58–65.
117. Johnson, S.L., The concept of fatigue in multiple sclerosis. J Neurosci Nurs 40:2 (2008), 72–77.
118. Archibald, C.J., McGrath, P.J., Ritvo, P.G., Fisk, J.D., Bhan, V., Maxner, C.E., et al. Pain prevalence, severity and impact in a clinic sample of multiple sclerosis patients. Pain 58:1 (1994), 89–93.
119. Kalia, L.V., Oconnor, P.W., Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Mult Scler J 11:3 (2005), 322–327.
120. Bol, Y., Smolders, J., Duits, A., Lange, I.M., Romberg-Camps, M., Hupperts, R., Fatigue and heat sensitivity in patients with multiple sclerosis. Acta Neurol Scand 126:6 (2012), 384–389.
121. Davis, S.L., Wilson, T.E., White, A.T., Frohman, E.M., Thermoregulation in multiple sclerosis. J Appl Physiol (1985) 109:5 (2010), 1531–1537.
122. McFarland, H.F., Martin, R., Multiple sclerosis: a complicated picture of autoimmunity. Nat Immunol 8:9 (2007), 913–919.
123. Ley, K., Molecular mechanisms of leukocyte recruitment in the inflammatory process. Cardiovasc Res 32:4 (1996), 733–742.
124. Lewen, A., Matz, P., Chan, P.H., Free radical pathways in CNS injury. J Neurotrauma 17:10 (2000), 871–890.
125. Van der Goes, A., Wouters, D., Van Der Pol, S.M., Huizinga, R., Ronken, E., Adamson, P., et al. Reactive oxygen species enhance the migration of monocytes across the blood-brain barrier in vitro. FASEB J 15:10 (2001), 1852–1854.
126. Bernardes, D., Brambilla, R., Bracchi-Ricard, V., Karmally, S., Dellarole, A., Carvalho-Tavares, J., et al. Prior regular exercise improves clinical outcome and reduces demyelination and axonal injury in experimental autoimmune encephalomyelitis. J Neurochem 136:Suppl. 1 (2016), 63–73.
127. Souza, P.S., Goncalves, E.D., Pedroso, G.S., Farias, H.R., Junqueira, S.C., Marcon, R., et al. Physical exercise attenuates experimental autoimmune encephalomyelitis by inhibiting peripheral immune response and blood-brain barrier disruption. Mol Neurobiol 54:6 (2017), 4723–4737.
128. Kim, T.W., Sung, Y.H., Regular exercise promotes memory function and enhances hippocampal neuroplasticity in experimental autoimmune encephalomyelitis mice. Neuroscience 346 (2017), 173–181.
129. Larocca, N.G., Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners. Patient 4:3 (2011), 189–201.
130. Pilutti, L.A., Greenlee, T.A., Motl, R.W., Nickrent, M.S., Petruzzello, S.J., Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis. Psychosom Med 75:6 (2013), 575–580.
131. Filippini, G., Munari, L., Incorvaia, B., Ebers, G.C., Polman, C., D'Amico, R., et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet 361:9357 (2003), 545–552.
132. Rampello, A., Franceschini, M., Piepoli, M., Antenucci, R., Lenti, G., Olivieri, D., et al. Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Phys Ther 87:5 (2007), 545–555.
133. Sabapathy, N.M., Minahan, C.L., Turner, G.T., Broadley, S.A., Comparing endurance- and resistance-exercise training in people with multiple sclerosis: a randomized pilot study. Clin Rehabil 25:1 (2011), 14–24.
134. Siegert, R., Abernethy, D., Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76:4 (2005), 469–475.
135. Arnett, P.A., Higginson, C.I., Voss, W.D., Wright, B., Bender, W.I., Wurst, J.M., et al. Depressed mood in multiple sclerosis: relationship to capacity-demanding memory and attentional functioning. Neuropsychology 13:3 (1999), 434–446.
136. Feinstein, A., An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:5 (2002), 674–678.
137. Ensari, I., Motl, R.W., Pilutti, L.A., Exercise training improves depressive symptoms in people with multiple sclerosis: results of a meta-analysis. J Psychosom Res 76:6 (2014), 465–471.
138. Koch, M., Uyttenboogaart, M., van Harten, A., Heerings, M., De Keyser, J., Fatigue, depression and progression in multiple sclerosis. Mult Scler 14:6 (2008), 815–822.
139. Jongen, P.J., Ter Horst, A.T., Brands, A.M., Cognitive impairment in multiple sclerosis. Minerva Med 103:2 (2012), 73–96.
140. Smith, P.J., Blumenthal, J.A., Hoffman, B.M., Cooper, H., Strauman, T.A., Welsh-Bohmer, K., et al. Aerobic exercise and neurocognitive performance: a meta-analytic review of randomized controlled trials. Psychosom Med 72:3 (2010), 239–252.
141. Beier, M., Bombardier, C.H., Hartoonian, N., Motl, R.W., Kraft, G.H., Improved physical fitness correlates with improved cognition in multiple sclerosis. Arch Phys Med Rehabil 95:7 (2014), 1328–1334.
142. Nocentini, U., Giordano, A., Di Vincenzo, S., Panella, M., Pasqualetti, P., The symbol digit modalities test - oral version: Italian normative data. Funct Neurol 21:2 (2006), 93–96.
143. Ptok, M., Buller, N., Kuske, S., Hecker, H., Verbaler Lern- und Merkfähigkeitstest. HNO 53:4 (2005), 369–375.
144. Briken, S., Gold, S.M., Patra, S., Vettorazzi, E., Harbs, D., Tallner, A., et al. Effects of exercise on fitness and cognition in progressive MS: a randomized, controlled pilot trial. Mult Scler 20:3 (2014), 382–390.
145. Wu, N., Minden, S.L., Hoaglin, D.C., Hadden, L., Frankel, D., Quality of life in people with multiple sclerosis: data from the Sonya Slifka Longitudinal Multiple Sclerosis Study. J Health Hum Serv Adm 30:3 (2007), 233–267.
146. Hobart, J., Lamping, D., Fitzpatrick, R., Riazi, A., Thompson, A., The multiple sclerosis impact scale (MSIS-29): a new patient-based outcome measure. Brain 124:Pt 5 (2001), 962–973.
147. Weinshenker, B.G., Bass, B., Rice, G.P., Noseworthy, J., Carriere, W., Baskerville, J., et al. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. Brain 112:Pt 1 (1989), 133–146.
148. Sutliff, M.H., Contribution of impaired mobility to patient burden in multiple sclerosis. Curr Med Res Opin 26:1 (2010), 109–119.
149. Dalgas, U., Stenager, E., Jakobsen, J., Petersen, T., Hansen, H.J., Knudsen, C., et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 73:18 (2009), 1478–1484.
150. Gehlsen, G.M., Grigsby, S.A., Winant, D.M., Effects of an aquatic fitness program on the muscular strength and endurance of patients with multiple sclerosis. Phys Ther 64:5 (1984), 653–657.
151. Petajan, J.H., Gappmaier, E., White, A.T., Spencer, M.K., Mino, L., Hicks, R.W., Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 39:4 (1996), 432–441.
152. Beer, S., Aschbacher, B., Manoglou, D., Gamper, E., Kool, J., Kesselring, J., Robot-assisted gait training in multiple sclerosis: a pilot randomized trial. Mult Scler 14:2 (2008), 231–236.
153. Snook, E.M., Motl, R.W., Effect of exercise training on walking mobility in multiple sclerosis: a meta-analysis. Neurorehabil Neural Repair 23:2 (2009), 108–116.
154. Cattaneo, D., Jonsdottir, J., Repetti, S., Reliability of four scales on balance disorders in persons with multiple sclerosis. Disabil Rehabil 29:24 (2007), 1920–1925.
155. Tarakci, E., Yeldan, I., Huseyinsinoglu, B.E., Zenginler, Y., Eraksoy, M., Group exercise training for balance, functional status, spasticity, fatigue and quality of life in multiple sclerosis: a randomized controlled trial. Clin Rehabil 27:9 (2013), 813–822.
156. Sosnoff, J., Motl, R.W., Snook, E.M., Wynn, D., Effect of a 4-week period of unloaded leg cycling exercise on spasticity in multiple sclerosis. NeuroRehabilitation 24:4 (2009), 327–331.
157. Giesser, B., Beres-Jones, J., Budovitch, A., Herlihy, E., Harkema, S., Locomotor training using body weight support on a treadmill improves mobility in persons with multiple sclerosis: a pilot study. Mult Scler 13:2 (2007), 224–231.
158. Pons-Estel, G.J., Alarcón, G.S., Scofield, L., Reinlib, L., Cooper, G.S., Understanding the epidemiology and progression of systemic lupus erythematosus. Semin Arthritis Rheum, 39(4), 2010, 257.
159. Bertsias, G., Ioannidis, J.P., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., et al. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 67:2 (2008), 195–205.
160. Burks, J.S., Bigley, G.K., Hill, H.H., Rehabilitation challenges in multiple sclerosis. Ann Indian Acad Neurol 12:4 (2009), 296–306.
161. Tench, C., Bentley, D., Vleck, V., McCurdie, I., White, P., D'Cruz, D., Aerobic fitness, fatigue, and physical disability in systemic lupus erythematosus. J Rheumatol 29:3 (2002), 474–481.
162. Pinto, A.J., Miyake, C.N., Benatti, F.B., Silva, C.A., Sallum, A.M., Borba, E., et al. Reduced aerobic capacity and quality of life in physically inactive patients with systemic lupus erythematosus with mild or inactive disease. Arthritis Care Res 68:12 (2016), 1780–1786.
163. Mancuso, C.A., Perna, M., Sargent, A.B., Salmon, J.E., Perceptions and measurements of physical activity in patients with systemic lupus erythematosus. Lupus 20:3 (2011), 231–242.
164. Krupp, L.B., LaRocca, N.G., Muir, J., Steinberg, A.D., A study of fatigue in systemic lupus erythematosus. J Rheumatol 17:11 (1990), 1450–1452.
165. McKinley, P.S., Ouellette, S.C., Winkel, G.H., The contributions of disease activity, sleep patterns, and depression to fatigue in systemic lupus erythematosus. A proposed model. Arthritis Rheum 38:6 (1995), 826–834.
166. ML, Wu, KH, Yu, Tsai, J.C., The effectiveness of exercise in adults with systemic lupus erythematosus: a systematic review and meta-analysis to guide evidence-based practice. Worldviews Evid-Based Nurs, 2017 (epub ahead of print).
167. Ramsey-Goldman, R., Schilling, E.M., Dunlop, D., Langman, C., Greenland, P., Thomas, R.J., et al. A pilot study on the effects of exercise in patients with systemic lupus erythematosus. Arthritis Care Res 13:5 (2000), 262–269.
168. MRPd, Carvalho, Sato, E.I., Tebexreni, A.S., RTC, Heidecher, Schenkman, S., TLB, Neto, Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus. Arthritis Care Res 53:6 (2005), 838–844.
169. Avaux, M., Hoellinger, P., Nieuwland-Husson, S., Fraselle, V., Depresseux, G., Houssiau, F.A., Effects of two different exercise programs on chronic fatigue in lupus patients. Acta Clin Belg 71:6 (2016), 403–406.
170. Benatti, F.B., Miossi, R., Passareli, M., Nakandakare, E.R., Perandini, L., Lima, F.R., et al. The effects of exercise on lipid profile in systemic lupus erythematosus and healthy individuals: a randomized trial. Rheumatol Int 35:1 (2015), 61–69.
171. Lamarche, B., Moorjani, S., Lupien, P.J., Cantin, B., Bernard, P.-M., Dagenais, G.R., et al. Apolipoprotein A-I and B levels and the risk of ischemic heart disease during a five-year follow-up of men in the Que'bec cardiovascular study. Circulation 94:3 (1996), 273–278.
172. Rosenson, R.S., Brewer, H.B. Jr., Davidson, W.S., Fayad, Z.A., Fuster, V., Goldstein, J., et al. Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport. Circulation 125:15 (2012), 1905–1919.
173. Greenberg, A.S., Nordan, R.P., McIntosh, J., Calvo, J.C., Scow, R.O., Jablons, D., Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Cancer Res 52:15 (1992), 4113–4116.
174. Esdaile, J.M., Abrahamowicz, M., Grodzicky, T., Li, Y., Panaritis, C., Berger, R.D., et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44:10 (2001), 2331–2337.
175. Chung, C.P., Avalos, I., Oeser, A., Gebretsadik, T., Shintani, A., Raggi, P., et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66:2 (2007), 208–214.
176. Aydemir, M., Yazisiz, V., Basarici, I., Avci, A.B., Erbasan, F., Belgi, A., et al. Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus. Lupus 19:3 (2010), 255–261.
177. Robert, M., Miossec, P., Effects of interleukin 17 on the cardiovascular system. Autoimmun Rev 16:9 (2017), 984–991.
178. do Prado, D.L., Gualano, B., Miossi, R., Sa-Pinto, A., Lima, F., Roschel, H., et al. Abnormal chronotropic reserve and heart rate recovery in patients with SLE: a case-control study. Lupus 20:7 (2011), 717–720.
179. Dogdu, O., Yarlioglues, M., Kaya, M.G., Ardic, I., Oguzhan, N., Akpek, M., et al. Deterioration of heart rate recovery index in patients with systemic lupus erythematosus. J Rheumatol 37:12 (2010), 2511–2515.
180. Miossi, R., Benatti, F.B., Lúciade de Sá Pinto, A., Lima, F.R., Borba, E.F., Prado, D.M.L., et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care Res 64:8 (2012), 1159–1166.
181. Edwards, K.M., Wilson, K.L., Sadja, J., Ziegler, M.G., Mills, P.J., Effects on blood pressure and autonomic nervous system function of a 12-week exercise or exercise plus DASH-diet intervention in individuals with elevated blood pressure. Acta Physiol (Oxford) 203:3 (2011), 343–350.
182. Routledge, F.S., Campbell, T.S., McFetridge-Durdle, J.A., Bacon, S.L., Improvements in heart rate variability with exercise therapy. Can J Cardiol 26:6 (2010), 303–312.
183. Doria, A., Iaccarino, L., Sarzi-Puttini, P., Atzeni, F., Turriel, M., Petri, M., Cardiac involvement in systemic lupus erythematosus. Lupus 14:9 (2005), 683–686.
184. Manzi, S., Meilahn, E.N., Rairie, J.E., Conte, C.G., Medsger, T.A. Jr., Jansen-McWilliams, L., et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol 145:5 (1997), 408–415.
185. dos Reis-Neto, E.T., da Silva, A.E., Monteiro, C.M., de Camargo, L.M., Sato, E.I., Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus. Rheumatology (Oxford) 52:12 (2013), 2187–2195.
186. Perandini, L.A., Sales-de-Oliveira, D., Almeida, D.C., Azevedo, H., Moreira-Filho, C.A., Cenedeze, M.A., et al. Effects of acute aerobic exercise on leukocyte inflammatory gene expression in systemic lupus erythematosus. Exerc Immunol Rev 22 (2016), 64–81.
187. Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. JAMA 289:14 (2003), 1799–1804.
188. Bultink, I.E., Lems, W.F., Kostense, P.J., Dijkmans, B.A., Voskuyl, A.E., Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 52:7 (2005), 2044–2050.
189. Manolagas, S.C., Jilka, R.L., Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:5 (1995), 305–311.
190. Kipen, Y., Briganti, E., Strauss, B., Will, R., Littlejohn, G., Morand, E., Three year followup of bone mineral density change in premenopausal women with systemic lupus erythematosus. J Rheumatol 26:2 (1999), 310–317.
191. Gudbjornsson, B., Hetta, J., Sleep disturbances in patients with systemic lupus erythematosus: a questionnaire-based study. Clin Exp Rheumatol 19:5 (2001), 509–514.
192. Da Costa, D., Bernatsky, S., Dritsa, M., Clarke, A.E., Dasgupta, K., Keshani, A., et al. Determinants of sleep quality in women with systemic lupus erythematosus. Arthritis Rheum 53:2 (2005), 272–278.
193. King, A.C., Oman, R.F., Brassington, G.S., Bliwise, D.L., Haskell, W.L., Moderate-intensity exercise and self-rated quality of sleep in older adults. A randomized controlled trial. JAMA 277:1 (1997), 32–37.
194. Van Belle, T.L., Coppieters, K.T., Von Herrath, M.G., Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 91:1 (2011), 79–118.
195. Los, E., Wilt, A., Diabetes mellitus, type 1, pediatric. StatPearls, 2017, StatPearls Publishing StatPearls Publishing LLC., Treasure Island (FL).
196. Thomas, N., Alder, E., Leese, G.P., Barriers to physical activity in patients with diabetes. Postgrad Med J 80:943 (2004), 287–291.
197. Brazeau, A.S., Mircescu, H., Desjardins, K., Dube, M.C., Weisnagel, S.J., Lavoie, C., et al. The barriers to physical activity in type 1 diabetes (BAPAD-1) scale: predictive validity and reliability. Diabete Metab 38:2 (2012), 164–170.
198. Burr, J.F., Shephard, R.J., Riddell, M.C., Physical activity in type 1 diabetes mellitus: assessing risks for physical activity clearance and prescription. Can Fam Physician 58:5 (2012), 533–535.
199. Brazeau, A.S., Rabasa-Lhoret, R., Strychar, I., Mircescu, H., Barriers to physical activity among patients with type 1 diabetes. Diabetes Care 31:11 (2008), 2108–2109.
200. Colberg, S.R., Sigal, R.J., Yardley, J.E., Riddell, M.C., Dunstan, D.W., Dempsey, P.C., et al. Physical activity/exercise and diabetes: a position statement of the American Diabetes Association. Diabetes Care 39:11 (2016), 2065–2079.
201. Kahn, J.K., Zola, B., Juni, J.E., Vinik, A.I., Decreased exercise heart rate and blood pressure response in diabetic subjects with cardiac autonomic neuropathy. Diabetes Care 9:4 (1986), 389–394.
202. Calver, A., Collier, J., Vallance, P., Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin-dependent diabetes. J Clin Invest 90:6 (1992), 2548–2554.
203. Tuomilehto, J., Borch-Johnsen, K., Molarius, A., Forsen, T., Rastenyte, D., Sarti, C., et al. Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland. Diabetologia 41:7 (1998), 784–790.
204. Kennedy, A., Nirantharakumar, K., Chimen, M., Pang, T.T., Hemming, K., Andrews, R.C., et al. Does exercise improve glycaemic control in type 1 diabetes? A systematic review and meta-analysis. PLoS ONE, 8(3), 2013.
205. Tonoli, C., Heyman, E., Roelands, B., Buyse, L., Cheung, S.S., Berthoin, S., et al. Effects of different types of acute and chronic (training) exercise on glycaemic control in type 1 diabetes mellitus: a meta-analysis. Sports Med 42:12 (2012), 1059–1080.
206. Chen, S.R., Lee, Y.J., Chiu, H.W., Jeng, C., Impact of physical activity on heart rate variability in children with type 1 diabetes. Childs Nerv Syst 24:6 (2008), 741–747.
207. Lucini, D., Zuccotti, G.V., Scaramuzza, A., Malacarne, M., Gervasi, F., Pagani, M., Exercise might improve cardiovascular autonomic regulation in adolescents with type 1 diabetes. Acta Diabetol 50:3 (2013), 341–349.
208. Langfort, J., Viese, M., Ploug, T., Dela, F., Time course of GLUT4 and AMPK protein expression in human skeletal muscle during one month of physical training. Scand J Med Sci Sports 13:3 (2003), 169–174.
209. Wadén, J., Forsblom, C., Thorn, L.M., Saraheimo, M., Rosengård-Bärlund, M., Heikkilä, O., et al. Physical activity and diabetes complications in patients with type 1 diabetes. The Finnish Diabetic Nephropathy (FinnDiane) Study, 31(2), 2008, 230–232.
210. LaPorte, R.E., Dorman, J.S., Tajima, N., Cruickshanks, K.J., Orchard, T.J., Cavender, D.E., et al. Pittsburgh insulin-dependent diabetes mellitus morbidity and mortality study: physical activity and diabetic complications. Pediatrics 78:6 (1986), 1027–1033.
211. Juutilainen, A., Lehto, S., Ronnemaa, T., Pyorala, K., Laakso, M., Similarity of the impact of type 1 and type 2 diabetes on cardiovascular mortality in middle-aged subjects. Diabetes Care 31:4 (2008), 714–719.
212. Seeger, J.P., Thijssen, D.H., Noordam, K., Cranen, M.E., Hopman, M.T., Nijhuis-van der Sanden, M.W., Exercise training improves physical fitness and vascular function in children with type 1 diabetes. Diabetes Obes Metab 13:4 (2011), 382–384.
213. Abraham, C., Cho, J.H., Inflammatory bowel disease. N Engl J Med 361:21 (2009), 2066–2078.
214. Shanahan, F., Crohn's disease. Lancet 359:9300 (2002), 62–69.
215. Terzić, J., Grivennikov, S., Karin, E., Karin, M., Inflammation and colon cancer. Gastroenterology 138:6 (2010), 2101–2114. e5.
216. Park, J.H., Peyrin-Biroulet, L., Eisenhut, M., Shin, J.I., IBD immunopathogenesis: a comprehensive review of inflammatory molecules. Autoimmun Rev 16:4 (2017), 416–426.
217. Khalili, H., Ananthakrishnan, A.N., Konijeti, G.G., Liao, X., Higuchi, L.M., Fuchs, C.S., et al. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ [Br Med J], 347, 2013.
218. Sonnenberg, A., Occupational distribution of inflammatory bowel disease among German employees. Gut 31:9 (1990), 1037–1040.
219. Persson, P.-G., Leijonmarck, C.-E., Bernell, O., Hellers, G., Ahlbom, A., Risk indicators for inflammatory bowel disease. Int J Epidemiol 22:2 (1993), 268–272.
220. Klein, I., Reif, S., Farbstein, H., Halak, A., Gilat, T., Preillness non dietary factors and habits in inflammatory bowel disease. Ital J Gastroenterol Hepatol 30:3 (1998), 247–251.
221. Cucino, C., Sonnenberg, A., Occupational mortality from inflammatory bowel disease in the United States 1991–1996. Am J Gastroenterol 96:4 (2001), 1101–1105.
222. Bøggild, H., Tüchsen, F., Ørhede, E., Occupation, employment status and chronic inflammatory bowel disease in Denmark. Int J Epidemiol 25:3 (1996), 630–637.
223. Brevinge, H., Berglund, B., Bosaeus, I., Tolli, J., Nordgren, S., Lundholm, K., Exercise capacity in patients undergoing proctocolectomy and small bowel resection for Crohn's disease. Br J Surg 82:8 (1995), 1040–1045.
224. Wiroth, J.B., Filippi, J., Schneider, S.M., Al-Jaouni, R., Horvais, N., Gavarry, O., et al. Muscle performance in patients with Crohn's disease in clinical remission. Inflamm Bowel Dis 11:3 (2005), 296–303.
225. Cook, M.D., Martin, S.A., Williams, C., Whitlock, K., Wallig, M.A., Pence, B.D., et al. Forced treadmill exercise training exacerbates inflammation and causes mortality while voluntary wheel training is protective in a mouse model of colitis. Brain Behav Immun 33 (2013), 46–56.
226. Saxena, A., Fletcher, E., Larsen, B., Baliga, M.S., Durstine, J.L., Fayad, R., Effect of exercise on chemically-induced colitis in adiponectin deficient mice. J Inflamm, 9(1), 2012, 30.
227. Hoffman-Goetz, L., Pervaiz, N., Packer, N., Guan, J., Freewheel training decreases pro- and increases anti-inflammatory cytokine expression in mouse intestinal lymphocytes. Brain Behav Immun 24:7 (2010), 1105–1115.
228. Hoffman-Goetz, L., Thorne, R., Houston, M., Splenic immune responses following treadmill exercise in mice. Can J Physiol Pharmacol 66:11 (1988), 1415–1419.
229. Hoffman-Goetz, L., Spagnuolo, P., Guan, J., Repeated exercise in mice alters expression of IL-10 and TNF-α in intestinal lymphocytes. Brain Behav Immun 22:2 (2008), 195–199.
230. Bernstein, C.N., Blanchard, J.F., Rawsthorne, P., Yu, N., The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol 96:4 (2001), 1116–1122.
231. Ince, G., Sarpel, T., Durgun, B., Erdogan, S., Effects of a multimodal exercise program for people with ankylosing spondylitis. Phys Ther 86:7 (2006), 924–935.
232. Lim, H.J., Moon, Y.I., Lee, M.S., Effects of home-based daily exercise therapy on joint mobility, daily activity, pain, and depression in patients with ankylosing spondylitis. Rheumatol Int 25:3 (2005), 225–229.
233. Fernandez-de-Las-Penas, C., Alonso-Blanco, C., Alguacil-Diego, I.M., Miangolarra-Page, J.C., One-year follow-up of two exercise interventions for the management of patients with ankylosing spondylitis: a randomized controlled trial. Am J Phys Med Rehabil 85:7 (2006), 559–567.
234. Siffledeen, J.S., Fedorak, R.N., Siminoski, K., Jen, H., Vaudan, E., Abraham, N., et al. Bones and Crohn's: risk factors associated with low bone mineral density in patients with Crohn's disease. Inflamm Bowel Dis 10:3 (2004), 220–228.
235. Robinson, R.J., Krzywicki, T., Almond, L., al-Azzawi, F., Abrams, K., Iqbal, S.J., et al. Effect of a low-impact exercise program on bone mineral density in Crohn's disease: a randomized controlled trial. Gastroenterology 115:1 (1998), 36–41.
236. Clauw, D.J., Fibromyalgia: a clinical review. JAMA 311:15 (2014), 1547–1555.
237. McBeth, J., Mulvey, M.R., Fibromyalgia: mechanisms and potential impact of the ACR 2010 classification criteria. Nat Rev Rheumatol 8:2 (2012), 108–116.
238. Phillips, K., Clauw, D.J., Central pain mechanisms in the rheumatic diseases: future directions. Arthritis Rheum 65:2 (2013), 291–302.
239. Dobkin, P.L., Abrahamowicz, M., Fitzcharles, M.A., Dritsa, M., da Costa, D., Maintenance of exercise in women with fibromyalgia. Arthritis Rheum 53:5 (2005), 724–731.
240. van Koulil, S., van Lankveld, W., Kraaimaat, F.W., van Helmond, T., Vedder, A., van Hoorn, H., et al. Tailored cognitive-behavioral therapy and exercise training for high-risk patients with fibromyalgia. Arthritis Care Res 62:10 (2010), 1377–1385.
241. Sanudo, B., Galiano, D., Using cardiovascular parameters and symptom severity to prescribe physical activity in women with fibromyalgia. Clin Exp Rheumatol 27:5 Suppl. 56 (2009), S62–6.
242. Jack, K., McLean, S.M., Moffett, J.K., Gardiner, E., Barriers to treatment adherence in physiotherapy outpatient clinics: a systematic review. Man Ther. 15:3 (2010), 220–228.
243. Bidonde, J.B.A., Schachter, C.L., Overend, T.J., Kim, S.Y., Góes, S.M., Boden, C., et al. Aerobic exercise training for adults with fibromyalgia. Cochrane Database Syst Rev, 2017.
244. Bidonde, J., Busch, A.J., Webber, S.C., Schachter, C.L., Danyliw, A., Overend, T.J., et al. Aquatic exercise training for fibromyalgia. Cochrane Database Syst Rev, 10, 2014.
245. Busch, A.J., Webber, S.C., Richards, R.S., Bidonde, J., Schachter, C.L., Schafer, L.A., et al. Resistance exercise training for fibromyalgia. Cochrane Database Syst Rev(12), 2013, Cd010884.
246. van West, D., Maes, M., Neuroendocrine and immune aspects of fibromyalgia. BioDrugs 15:8 (2001), 521–531.
247. Cunha, F.Q., Lorenzetti, B.B., Poole, S., Ferreira, S.H., Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 104:3 (1991), 765–767.
248. Yadav, A.K., Kumar, V., Jha, V., Heat shock proteins 60 and 70 specific proinflammatory and cytotoxic response of CD4 + CD28null cells in chronic kidney disease. Mediat Inflamm, 2013, 2013, 9.
249. Bote, M.E., Garcia, J.J., Hinchado, M.D., Ortega, E., Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise. PLoS ONE, 8(9), 2013, e74524.
250. Arnold, L.M., Choy, E., Clauw, D.J., Goldenberg, D.L., Harris, R.E., Helfenstein, M., et al. Fibromyalgia and chronic pain syndromes: a white paper detailing current challenges in the field. Clin J Pain 32:9 (2016), 737–746.
251. Hinchcliff, M., Varga, J., Systemic sclerosis/scleroderma: a treatable multisystem disease. Am Fam Physician 78:8 (2008), 961–968.
252. Mostmans, Y., Cutolo, M., Giddelo, C., Decuman, S., Melsens, K., Declercq, H., et al. The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review. Autoimmun Rev 16:8 (2017), 774–786.
253. LeRoy, E.C., Medsger, T.A. Jr., Criteria for the classification of early systemic sclerosis. J Rheumatol 28:7 (2001), 1573–1576.
254. Boonstra, M., Huizinga, T.W.J., de Vries-Bouwstra, J.K., Auto-antibodies and cancer in systemic sclerosis. Autoimmun Rev 16:8 (2017), 883–884.
255. Walker, U.A., Tyndall, A., Czirjak, L., Denton, C., Farge-Bancel, D., Kowal-Bielecka, O., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 66:6 (2007), 754–763.
256. Ali, H., Ng, K.R., Low, A.H., A qualitative systematic review of the prevalence of coronary artery disease in systemic sclerosis. Int J Rheum Dis 18:3 (2015), 276–286.
257. Almeida, C., Almeida, I., Vasconcelos, C., Quality of life in systemic sclerosis. Autoimmun Rev 14:12 (2015), 1087–1096.
258. Alexanderson, H., Bergegard, J., Bjornadal, L., Nordin, A., Intensive aerobic and muscle endurance exercise in patients with systemic sclerosis: a pilot study. BMC Res Notes, 7, 2014, 86.
259. Oliveira, N.C., dos Santos Sabbag, L.M., de Sa Pinto, A.L., Borges, C.L., Lima, F.R., Aerobic exercise is safe and effective in systemic sclerosis. Int. J. Sports Med. 30:10 (2009), 728–732.
260. Rannou, F., Boutron, I., Mouthon, L., Sanchez, K., Tiffreau, V., Hachulla, E., et al. Personalized physical therapy versus usual care for patients with systemic sclerosis: a randomized controlled trial. Arthritis Care Res 69:7 (2017), 1050–1059.
261. Someya, F., Mugii, N., Hasegawa, M., Yahata, T., Nakagawa, T., Predictors of exercise-induced oxygen desaturation in systemic sclerosis patients with interstitial lung disease. Respir Care 59:1 (2014), 75–80.
262. Voilliot, D., Magne, J., Dulgheru, R., Kou, S., Henri, C., Laaraibi, S., et al. Determinants of exercise-induced pulmonary arterial hypertension in systemic sclerosis. Int J Cardiol 173:3 (2014), 373–379.
263. Oliveira, N.C., dos Santos Sabbag, L.M., de Sa Pinto, A.L., Borges, C.L., Lima, F.R., Aerobic exercise is safe and effective in systemic sclerosis. Int J Sports Med 30:10 (2009), 728–732.
264. Antonioli, C.M., Bua, G., Frigè, A., Prandini, K., Radici, S., Scarsi, M., et al. An individualized rehabilitation program in patients with systemic sclerosis may improve quality of life and hand mobility. Clin Rheumatol 28:2 (2009), 159–165.
265. Pinto, A.L., Oliveira, N.C., Gualano, B., Christmann, R.B., Painelli, V.S., Artioli, G.G., et al. Efficacy and safety of concurrent training in systemic sclerosis. J Strength Cond Res 25:5 (2011), 1423–1428.
266. Schouffoer, A.A., Ninaber, M.K., Beaart-van de Voorde, L.J.J., van der Giesen, F.J., de Jong, Z., Stolk, J., et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res 63:6 (2011), 909–917.
267. Schön, M.P., Boehncke, W.H., Psoriasis. N Engl J Med 352:18 (2005), 1899–1912.
268. Parisi, R., Symmons, D.P.M., Griffiths, C.E.M., Ashcroft, D.M., Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Investig Dermatol 133:2 (2013), 377–385.
269. Frankel, H.C., Han, J., Li, T., Qureshi, A.A., The association between physical activity and the risk of incident psoriasis. Arch Dermatol 148:8 (2012), 918–924.
270. Nicklas, B.J., Hsu, F.C., Brinkley, T.J., Church, T., Goodpaster, B.H., Kritchevsky, S.B., et al. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J Am Geriatr Soc 56:11 (2008), 2045–2052.
271. Torres, T., Alexandre, J.M., Mendonca, D., Vasconcelos, C., Silva, B.M., Selores, M., Levels of physical activity in patients with severe psoriasis: a cross-sectional questionnaire study. Am J Clin Dermatol 15:2 (2014), 129–135.
272. Ramsay, B., O'Reagan, M., A survey of the social and psychological effects of psoriasis. Br J Dermatol 118:2 (1988), 195–201.
273. Leibowitz, E., Seidman, D.S., Laor, A., Shapiro, Y., Epstein, Y., Are psoriatic patients at risk of heat intolerance?. Br J Dermatol 124:5 (1991), 439–442.
274. Ferro, F., Vagelli, R., Bruni, C., Cafaro, G., Marcucci, E., Bartoloni, E., et al. One year in review 2016: Sjogren's syndrome. Clin Exp Rheumatol 34:2 (2016), 161–171.
275. Garcia-Carrasco, M., Jimenez-Herrera, E.A., Galvez-Romero, J.L., de Lara, L.V., Mendoza-Pinto, C., Etchegaray-Morales, I., et al. Vitamin D and Sjogren syndrome. Autoimmun Rev 16:6 (2017), 587–593.
276. Ng, W.-F., Miller, A., Bowman, S.J., Price, E.J., Kitas, G.D., Pease, C., et al. Physical activity but not sedentary activity is reduced in primary Sjögren's syndrome. Rheumatol Int 37:4 (2017), 623–631.
277. Strombeck, B.E., Theander, E., Jacobsson, L.T., Effects of exercise on aerobic capacity and fatigue in women with primary Sjogren's syndrome. Rheumatology (Oxford) 46:5 (2007), 868–871.
278. Miossi, R., Benatti, F.B., Luciade de Sa Pinto, A., Lima, F.R., Borba, E.F., Prado, D.M., et al. Using exercise training to counterbalance chronotropic incompetence and delayed heart rate recovery in systemic lupus erythematosus: a randomized trial. Arthritis Care Res 64:8 (2012), 1159–1166.